Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study캐나다에서 7가 및 13가 폐렴구균 결합 백신의 백신 효과: IMPACT 연구Article Published on 2022-04-262024-08-24 Journal: Vaccine [Category] 폐렴구균 감염증, [키워드] invasive pneumococcal disease pneumococcal conjugate vaccines pneumococcus Streptococcus pneumoniae vaccine effectiveness [DOI] 10.1016/j.vaccine.2022.03.048
Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers실생활에서 코로나백의 약화 효과: 의료 종사자를 대상으로 한 후향적 코호트 연구Article Published on 2022-04-202022-09-11 Journal: Vaccine [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted Alpha Alpha variant association booster dose booster doses clinical trials conducted CoronaVac COVID-19 COVID-19 disease COVID-19 infection COVID-19 infections COVID-19 vaccine Cox regression defined demonstrated determine dominant dose doses Effectiveness follow-up period groups Health care Health care worker health care workers Inactivated vaccine incidence rate İstanbul positive PCR test rate ratio receive receiving reduce retrospective cohort study SARS-COV-2 infection second dose test result the vaccine Turkey university hospital vaccination Vaccine vaccine effectiveness variant variants were used [DOI] 10.1016/j.vaccine.2022.03.032 PMC 바로가기 [Article Type] Article
Effectiveness of the Comirnaty and the Vaxzevria vaccines in preventing SARS-CoV-2 infection among residents in Lazio region (Italy)Article Published on 2022-04-202023-07-08 Journal: Vaccine [Category] COVID19(2023년), [키워드] cohort study Comirnaty COVID-19 SARS-COV-2 infection vaccine effectiveness Vaxzevria. [DOI] 10.1016/j.vaccine.2022.02.063 PMC 바로가기
Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, CanadaArticle Published on 2022-04-192023-06-17 Journal: Clinical Infectious Diseases: An Official Publicat [Category] MERS, SARS, [키워드] Heterologous SARS-CoV-2 test-negative design vaccine effectiveness waning [DOI] 10.1093/cid/ciac290 PMC 바로가기
Prevention of Coronavirus Disease 2019 (COVID-19) by mRNA-Based Vaccines Within the General Population of CaliforniaArticle Published on 2022-04-152023-07-02 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, [키워드] COVID-19 Real-world evidence test-negative design vaccine effectiveness [DOI] 10.1093/cid/ciab640 PMC 바로가기
Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 eraArticle Published on 2022-04-112023-06-14 Journal: Vaccine [Category] MERS, 신종인플루엔자, [키워드] children COVID-19 era Influenza test-negative design Vaccine vaccine effectiveness [DOI] 10.1016/j.vaccine.2022.04.033 PMC 바로가기 [Article Type] Article
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant RecipientsArticle Published on 2022-04-062023-06-15 Journal: The Journal of Infectious Diseases [Category] MERS, [키워드] COVID-19 Immunocompromised SARS-CoV-2 solid organ transplantation vaccine effectiveness [DOI] 10.1093/infdis/jiac118 PMC 바로가기
CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control studyResearch Article Published on 2022-04-052023-06-30 Journal: BMC Medicine [Category] COVID19(2023년), SARS, [키워드] COVID-19 Inactivated vaccine pregnant women SARS-CoV-2 vaccine effectiveness [DOI] 10.1186/s12916-022-02353-w PMC 바로가기 [Article Type] Research Article
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studiesReview Published on 2022-04-012023-07-08 Journal: Expert review of vaccines [Category] COVID19(2023년), [키워드] COVID-19 vaccines COVID-19-related hospitalization Immunocompromised SARS-COV-2 infection symptomatic COVID-19 illness vaccine effectiveness [DOI] 10.1080/14760584.2022.2035222 PMC 바로가기 [Article Type] Review
Outbreak of SARS-CoV-2 B.1.617.2 (delta) variant in a nursing home 28 weeks after two doses of mRNA anti-COVID-19 vaccines: evidence of a waning immunitymRNA 항-COVID-19 백신 2회 접종 후 28주 만에 요양원에서 SARS-CoV-2 B.1.617.2(델타) 변종 발생: 면역 약화의 증거Article Published on 2022-04-012022-09-11 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] 48 hour 48 hours 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration Anti-spike anti-Spike IgG Antibody Units B.1.617.2 B.1.617.2 SARS-CoV-2 variant binding antibody unit booster dose collected coronavirus coronavirus disease Coronavirus disease 2019 Coverage COVID-19 Delta diagnosed dose Effectiveness Evidence expressed Fisher exact test health worker health workers higher risk IgG Immunity index case Infection Italy Lineage material mRNA mRNA vaccine Neutralizing nursing home nursing home residents outbreak Quantitative Relative risk resident respiratory resulting risk RT-PCR SARS-CoV-2 SARS-COV-2 infection second dose Sequencing sera serum severe acute respiratory syndrome Coronavirus severe coronavirus disease severe COVID-19 severe disease titre vaccination Vaccine vaccine effectiveness variant waning immunity was determined was measured was performed WHO [DOI] 10.1016/j.cmi.2021.12.013 PMC 바로가기 [Article Type] Article